Literature DB >> 27481742

Acetate-buffered crystalloid fluids: Current knowledge, a systematic review.

Carmen A Pfortmueller1, Edith Fleischmann2.   

Abstract

INTRODUCTION: The concept of fluid resuscitation with balanced solutions containing acetate is relatively new. The knowledge about acetate mostly originates from nephrological research, as acetate was primarily used as a dialysis buffer where much higher doses of acetate are infused. The aim of this review is to give an overview of the advantages and disadvantages of an acetate-buffered crystalloid fluid when compared with other crystalloid infusates.
METHODS: We report trials with the primary object of comparing an acetate-buffered infusion solute to another crystalloid infusate. A systematic literature search of MEDLINE and the Cochrane Controlled Clinical trials register was conducted to identify suitable studies.
RESULTS: The search strategy used produced 1205 potential titles. After eliminating doubles, 312 titles and abstracts were screened, and 31 references were retrieved for full-text analysis. A total of 27 scientific studies were included in the study.
CONCLUSION: Acetate-buffered crystalloid solutes do have a favorable influence on microcirculation. To what extent the acetate-buffered crystalloids influence kidney function is controversially discussed and not yet clear. Metabolic alkalosis did not occur in a single study in humans after an acetate-buffered infusate; potassium levels stayed stable in all studies. Cardiac output and contractility seem to be positively influenced; nonetheless, data on maintenance of a target blood pressure remain inconclusive. Whether acetate-buffered crystalloid fluids lead to lower rates of acute kidney injury and increased survival when compared with normal saline is yet unclear and may depend on the amount of fluid administered.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetate; Acetate buffered; Crystalloid; Infusion therapy; Lactate buffered; Normal saline

Mesh:

Substances:

Year:  2016        PMID: 27481742     DOI: 10.1016/j.jcrc.2016.05.006

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  14 in total

Review 1.  0.9% NaCl (Normal Saline) - Perhaps not so normal after all?

Authors:  Neil Blumberg; Jill M Cholette; Anthony P Pietropaoli; Richard Phipps; Sherry L Spinelli; Michael P Eaton; Suzie A Noronha; Jerard Seghatchian; Joanna M Heal; Majed A Refaai
Journal:  Transfus Apher Sci       Date:  2018-02-21       Impact factor: 1.764

Review 2.  Crystalloid fluid choice in the critically ill : Current knowledge and critical appraisal.

Authors:  Carmen A Pfortmueller; Barbara Kabon; Joerg C Schefold; Edith Fleischmann
Journal:  Wien Klin Wochenschr       Date:  2018-03-02       Impact factor: 1.704

3.  N-Acetyl cysteine abrogates silver-induced reactive oxygen species in human cells without altering silver-based antimicrobial activity.

Authors:  Kush N Shah; Parth N Shah; Andrew R Mullen; Qingquan Chen; Marie R Southerland; Bhagath Chirra; Ralph J DeBerardinis; Carolyn L Cannon
Journal:  Toxicol Lett       Date:  2020-07-10       Impact factor: 4.372

4.  Normal saline versus Normosol™-R in sepsis resuscitation: A retrospective cohort study.

Authors:  Ryan A Duffy; Mathab B Foroozesh; Robert D Loflin; Susanti R Ie; Bradley L Icard; Allison N Tegge; Jonathan R Nogueira; Damon R Kuehl; Dan C Smith; Anthony L Loschner
Journal:  J Intensive Care Soc       Date:  2018-07-05

5.  Bicarbonate Ringer's solution for early resuscitation in hemorrhagic shock rabbits.

Authors:  Long Wang; Jingsheng Lou; Jiangbei Cao; Tao Wang; Jing Liu; Weidong Mi
Journal:  Ann Transl Med       Date:  2021-03

Review 6.  Serum chloride levels in critical illness-the hidden story.

Authors:  Carmen Andrea Pfortmueller; Dominik Uehlinger; Stephan von Haehling; Joerg Christian Schefold
Journal:  Intensive Care Med Exp       Date:  2018-04-13

Review 7.  Normal saline for intravenous fluid therapy in critically ill patients.

Authors:  Fei-Hu Zhou; Chao Liu; Zhi Mao; Peng-Lin Ma
Journal:  Chin J Traumatol       Date:  2018-01-31

8.  Fluid management in patients undergoing cardiac surgery: effects of an acetate- versus lactate-buffered balanced infusion solution on hemodynamic stability (HEMACETAT).

Authors:  Carmen A Pfortmueller; Livia Faeh; Martin Müller; Balthasar Eberle; Hansjörg Jenni; Björn Zante; Josef Prazak; Lars Englberger; Jukka Takala; Stephan M Jakob
Journal:  Crit Care       Date:  2019-05-06       Impact factor: 9.097

9.  Balanced crystalloids for intravenous fluid therapy in critically ill and non-critically ill patients: A protocol for systematic review and network meta-analyses.

Authors:  Peifen Ma; Bo Wang; Jun Zhang; Xiping Shen; Liping Yu; Xinman Dou
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

Review 10.  Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA).

Authors:  Manu L N G Malbrain; Thomas Langer; Djillali Annane; Luciano Gattinoni; Paul Elbers; Robert G Hahn; Inneke De Laet; Andrea Minini; Adrian Wong; Can Ince; David Muckart; Monty Mythen; Pietro Caironi; Niels Van Regenmortel
Journal:  Ann Intensive Care       Date:  2020-05-24       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.